Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012872 (
DNA marker
)
929
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report the isolation and characterization of a novel
DNA marker
(
1A1
) in Xqter in the region of the fragile X. Genetic studies in families segregating for the fragile X syndrome suggest that
1A1
lies between the disease mutation and the distal locus, DXS52. Studies in normal and fragile X families show that
1A1
is tightly linked to DXS52 (Zmax = 17.20; theta max = 0.03) and F8 (Zmax = 7.01; theta max = 0.08). Multipoint mapping of families supports the order Xcen-DXS105-FRAXA-
1A1
-DXS52-(F8, DXS115)-Xqter. Pulsed-field gel electrophoresis (PFGE) studies demonstrate that
1A1
defines a new region of at least 2 Mb of DNA not physically linked to DXS52 or F8, thus extending the physical map of Xq27-qter to over 4 Mb. Complex partial digestion PFGE patterns, probably due to differing degrees of methylation, are observed with
1A1
in unrelated normal and fragile-X-positive individuals, whereas other distal markers give uniform digestion profiles. Physical data suggest that
1A1
lies in a region less CpG rich than other distal markers in Xq27-qter.
...
PMID:Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome. 274 66